Read news on Eradivir with our app.
Read more in the app
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza - EurekAlert
Eradivir’s EV25 therapeutic proven to reduce - EurekAlert
Eradivir's EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies
